Abstract
The chitosan added to heparinized blood plasma in vitro at concentrations of 10–2, 10–1, 1, 5, and 10 mg/mL dose-dependent reduced fibrinolysis, the prothrombin time, platelet aggregation, and blood clotting and increased the activity of factor XIIIa. A decrease in fibrinolysis and plasmin activity and increased FXIIIa activity and platelet aggregation were also detected in vivo in a rat model with hypocoagulation caused by intravenous administration of high-molecular heparin (400 IU/kg of body mass), 30 minutes after injection of chitosan (10 mg/kg of body mass). At the same time, the fibrinogen concentration was restored to the normal levels. It was accompanied by an increase in the activity of the tissue plasminogen activator and an extension of the blood clotting time (APTT test). A conclusion on the multidirectional effect of chitosan on the hemostasis parameters under hypocoagulation was made, and the possible mechanisms of chitosan action were considered.
Similar content being viewed by others
REFERENCES
Aktop, S., Emekli-Alturfan, E., Ozer, C., Gonul, O., Garip, H., Yarat, A., and Goker, K., Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats, Clin. Appl. Thromb. Hemost., 2014, vol. 20, no. 1, pp. 16–21.
Barkagan, Z.S. and Momot, A.P., Diagnostika i kontroliruemaya terapiya sistemy gemostaza (Diagnosis and Controlled Therapy of the Hemostasis System), Moscow: N’yudiamed, 2008.
Cassano, M., Di Gioia, M.L., Mellace, S., Picci, N., and Trombino, S., Hemostatic gauze based on chitosan and hydroquinone: preparation, characterization and blood coagulation evaluation, J. Mater. Sci. Mater. Med., 2017, vol. 28, no. 12, p. 190.
Chou, T.C., Fu, E., Wu, C.J., and Yeh, J.H., Chitosan enhances platelet adhesion and aggregation, Biochem. Biophys. Res. Commun., 2003, vol. 302, no. 3, pp. 480–483.
Drozd, N.N. and Makarov, V.A., Anticoagulant activity of substances, nano- and microstructures based on chitosan derivatives, in Khitozan: sbornik statei (Chitosan: Collection of Papers), Skryabin, K.G., Mikhailov, S.N., and Varlamov, V.P., Eds., Moscow: Tsentr Bioinzheneriya, 2013.
Guo, X., Sun, T., Zhong, R., Ma, L., You, C., Tian, M., Li, H., and Wang, C., Effects of chitosan oligosaccharides on human blood components, Front. Pharmacol., 2018, vol. 3, no. 9, p. 1412.
Hu, Z., Lu, S., Cheng, Y., Kong, S., Li, S., Li, C., and Yang, L., Investigation of the effects of molecular parameters on the hemostatic properties of chitosan, Molecules, 2018, vol. 23, no. 12, p. 3147.
Kuznik, B.I., Kletochnye i molekulyarnye mekhanizmy regulyatsii sistemy gemostaza v norme i patologii (Cellular and Molecular Mechanisms of Regulation of the Hemostasis System in Normal and Pathological Conditions), Chita: Ekspress Izd., 2010.
Lestari, W., Yusry, W., Haris, M.S., Jaswir, I., and Idrus, E., A glimpse on the function of chitosan as a dental hemostatic agent, Jpn. Dent. Sci. Rev., 2020, vol. 56, no. 1, pp. 147–154.
Lyapina, L.A., Grigorjeva, M.E., Obergan, T.Yu., and Shubina, T.A., Teoreticheskie i prakticheskie voprosy izucheniya funktsional’nogo sostoyaniya protivosvertyvayushchei sistemy krovi (Theoretical and Practical Issues of Studying the Functional State of the Blood Anticoagulant System), Moscow: Advanced Solutions, 2012.
Naveed, M., Phil, L., Sohail, M., Hasnat, M., Baig, M.M.F.A., Ihsan, A.U., Shumzaid, M., Kakar, M.U., Mehmood Khan, T., Akabar, M.D., Hussain, M.I., and Zhou, Q.G., Chitosan oligosaccharide (COS): an overview, Int. J. Biol. Macromol., 2019, vol. 15, no. 129, pp. 827–843.
Tolstenkov, S.A., Drozd, N.N., Makarov, V.A., and Bannikova, G.E., Biospecific electrophoresis of complexes between low molecular weight heparins and chitosans, Materialy 8-oi mezhdunarodnoi konferentsii (Proc. 8th Int. Conf.), Moscow, 2006, pp. 253–256.
Yang, Z., Han, B., Dawei, Fu.D., and Liu, W., Acute toxicity of high dosage carboxymethyl chitosan and its effect on the blood parameters in rats, J. Mater. Sci. Mater. Med., 2012, vol. 23, no. 2, pp. 457–462.
Zhang, W., Zhong, D., Liu, Q., and Zhang, Y., Effect of chitosan and carboxymethyl chitosan on fibrinogen structure and blood coagulation, J. Biomater. Sci. Polym. Ed., 2013, vol. 24, no. 13, pp. 1549–1563.
ACKNOWLEDGMENTS
The authors are grateful to G.Yu. Lyapin who facilitated the work.
Funding
This work was carried out with the financial support of the Moscow State University on the state budgetary fundamental topic “Regulators of the coagulation and anticoagulation systems in normal and pathological conditions” (Cytis no. 121032300076-3).
Author information
Authors and Affiliations
Contributions
The idea of work and planning of the experiment: L.A. Lyapina and M.E. Grigorjeva; conducting experiments: all authors; data processing: all authors; article writing: L.A. Lyapina and M.E. Grigorjeva; article editing: T.Yu. Obergan.
Corresponding author
Ethics declarations
Conflict of interest. The authors declare no conflicts of interest.
Statement on the welfare of animals. All procedures performed in studies involving animals met the ethical standards approved by the legal acts of the Russian Federation, the principles of the Basel Declaration, and the documents recommended by the European Science Foundation and the Declaration of Helsinki on humane treatment of animals.
Additional information
Translated by M. Shulskaya
Rights and permissions
About this article
Cite this article
Lyapina, L.A., Obergan, T.Y., Grigorjeva, M.E. et al. The Effect of Chitosan on Blood Coagulation in Heparinized Rats. Biol Bull Russ Acad Sci 49, 666–670 (2022). https://doi.org/10.1134/S1062359022060097
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359022060097